Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL7592015

CN(C)C(=O)Cc1ccc2c(c1)CC2.N

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
LMNA P02545 2/20 0.43
PARP1 P09874 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HPGD P15428 4/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CYP2D6 P10635 1/20 0.42
AKR1B1 P15121 2/20 0.41
MAPT P10636 2/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40
CYP2C9 P11712 1/20 0.40
DUSP3 P51452 1/20 0.39
PTPN5 P54829 1/20 0.39
PTPN11 Q06124 1/20 0.39
KEAP1 Q14145 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7844764 0.81 AKR1B1 (0.50) PARP1AKR1B1
SCHEMBL31478167 0.76 AKR1B1 (0.58) ALDH1A1LMNAMEN1KMT2AHPGD
SCHEMBL31478141 0.75 LMNA (0.46) ALDH1A1LMNAHPGDCYP1A2CYP2C19
SCHEMBL9313893 0.73 KDM4E (0.60) ALDH1A1LMNAPARP1MEN1KMT2A
SCHEMBL7650955 0.73 ALDH1A1 (0.55) ALDH1A1LMNAMEN1KMT2AHPGD
Ammonia Solution, Strong SCHEMBL7590346 0.72 MTNR1A (0.44) ALDH1A1LMNAMEN1KMT2AHPGD
SCHEMBL10616782 0.71 SIGMAR1 (0.52) ALDH1A1MEN1KMT2ACYP1A2CYP2C19
Hydrochloric Acid SCHEMBL28989826 0.71 KDM4E (0.58) ALDH1A1LMNAPARP1MEN1KMT2A
SCHEMBL12608352 0.71 ALDH1A1 (0.54) ALDH1A1LMNAMEN1KMT2AHPGD
SCHEMBL10665217 0.71 PARP1 (0.46) ALDH1A1PARP1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6368573-B1 MEASURING MYOCARDIAL FUNCTION IN MAMMAL KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. 2002-04-09 US disclosed
US-5063233-A Cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1991-11-05 US disclosed
US-5034381-A Antagonist CIBA-GEIGY CORPORATION (US) 1991-07-23 US disclosed
US-4968697-A ADENOSINE-2 RECEPTOR AGONISTS CIBA-GEIGY CORPORATION (US) 1990-11-06 US disclosed
US-4954504-A Hypotensive agents, psychotic disorders CIBA-GEIGY CORPORATION (US) 1990-09-04 US disclosed
EP-0323807-A2 Certain 2-substituted adenosine derivatives CIBA-GEIGY AG (CH) 1989-07-12 EP disclosed
EP-0277917-A2 Certain adenosine 5'-carboxamide derivatives CIBA-GEIGY AG (CH) 1988-08-10 EP disclosed
EP-0267878-A1 N9-cyclopentyl-substituted adenine derivatives CIBA-GEIGY AG (CH) 1988-05-18 EP disclosed